Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 3Completed 2Withdrawn 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma 1

Interventions

selinexor 3pegaspargase 3Oxaliplatin 2Gemcitabine 2tislelizumab 1sugemalimab 1Thiotepa 1Radiotherapy 1Immune Checkpoint Inhibitors 1Azacitidine 1Asparaginase 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Lymphoma, Extranodal NK-T-Cell × Asparaginase × Clear all
NCT07554482 2026-04-28

Selinexor Combined With Reduced-Dose Radiotherapy For Early-Stage Extranodal NK/T-Cell Lymphoma

Beijing Tongren Hospital

Phase 2 Not yet recruiting
34 enrolled
Lymphoid

Lymphoma, Extranodal NK-T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡